SCM
AGN

Stonebridge Capital Management’s Allergan plc AGN Stock Holding History

Stonebridge Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,260
Closed -$436K – 154
2018
Q4 		$436K Sell
3,260
-2,916
-47% -$478K 0.17% 82
2018
Q3 		$1.18M Sell
6,176
-420
-6% -$77.2K 0.4% 54
2018
Q2 		$1.14M Buy
6,596
+850
+15% +$136K 0.41% 55
2018
Q1 		$944K Buy
5,746
+1,064
+23% +$178K 0.35% 60
2017
Q4 		$824K Buy
4,682
+1,613
+53% +$289K 0.29% 62
2017
Q3 		$629K Buy
3,069
+1,255
+69% +$292K 0.24% 71
2017
Q2 		$441K Hold
1,814
– – 0.17% 86
2017
Q1 		$434K Sell
1,814
-112
-6% -$26.1K 0.18% 82
2016
Q4 		$404K Buy
+1,926
New +$399K 0.17% 84

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Stonebridge Capital Management's AGN Position: Q1 2019 in Review

Stonebridge Capital Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 3,260 shares — an estimated $436K sold.

Stonebridge Capital Management first reported a position in AGN in Q4 2016 and held it in 9 quarters. The position peaked at $1.18M in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Stonebridge Capital Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Stonebridge Capital Management sold 3,260 Allergan plc shares in Q1 2019, an estimated $436K.
  • Stonebridge Capital Management first reported a position in Allergan plc in Q4 2016 and held it in 9 quarters.
  • Stonebridge Capital Management's Allergan plc position peaked at $1.18M in Q3 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Stonebridge Capital Management's 13F filing for Q1 2019, filed 2 May 2019.